Matches in Wikidata for { <http://www.wikidata.org/entity/Q66046617> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q66046617 description "clinical trial" @default.
- Q66046617 description "ensayu clínicu" @default.
- Q66046617 description "klinisch onderzoek" @default.
- Q66046617 description "клінічне випробування" @default.
- Q66046617 description "կլինիկական փորձարկում" @default.
- Q66046617 name "SL-401 in Combination With Azacitidine in Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)" @default.
- Q66046617 name "SL-401 in Combination With Azacitidine in Acute Myeloid Leukemia" @default.
- Q66046617 type Item @default.
- Q66046617 label "SL-401 in Combination With Azacitidine in Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)" @default.
- Q66046617 label "SL-401 in Combination With Azacitidine in Acute Myeloid Leukemia" @default.
- Q66046617 prefLabel "SL-401 in Combination With Azacitidine in Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)" @default.
- Q66046617 prefLabel "SL-401 in Combination With Azacitidine in Acute Myeloid Leukemia" @default.
- Q66046617 P1050 Q66046617-3249F568-EF1A-43C7-8D05-A169E37C2E24 @default.
- Q66046617 P1050 Q66046617-3C58C1E9-BD05-46FC-A4DE-52238729F750 @default.
- Q66046617 P1132 Q66046617-8BB9C66E-85CF-4833-A5AE-E330B3EB6DC8 @default.
- Q66046617 P1476 Q66046617-E2FB6D0B-B1A2-4F0B-AB87-295ACADA6F8E @default.
- Q66046617 P17 Q66046617-4E1878FD-2D92-4C61-BB2E-0C504211C350 @default.
- Q66046617 P2899 Q66046617-16381C4E-B792-40EC-9994-21D458129D39 @default.
- Q66046617 P3098 Q66046617-97629746-8AD4-496A-9077-4127229327DA @default.
- Q66046617 P31 Q66046617-44C7F1E6-A6A6-462C-978F-8730385863F6 @default.
- Q66046617 P580 Q66046617-208B2A60-8209-4C85-9F3F-FF199A9BCB29 @default.
- Q66046617 P582 Q66046617-1FE347BC-556A-48E2-984E-A120B25CC54B @default.
- Q66046617 P6099 Q66046617-411A56C6-1562-41C5-8C93-58E3889E479C @default.
- Q66046617 P6153 Q66046617-9C9C0898-06F4-4FD9-8648-C07ADDDAD284 @default.
- Q66046617 P8363 Q66046617-1E1B44E7-655F-452E-91FB-1293E614499E @default.
- Q66046617 P921 Q66046617-65BF6BA0-4FEB-4061-AE57-724FE41A6628 @default.
- Q66046617 P1050 Q179630 @default.
- Q66046617 P1050 Q29496 @default.
- Q66046617 P1132 "+36" @default.
- Q66046617 P1476 "Phase 1 Study of SL-401 in Combination With Azacitidine in Relapsed/Refractory Acute Myeloid Leukemia (AML) or in Treatment-Naive AML Not Eligible for Standard Therapy or in Subjects With High-Risk Myelodysplastic Syndrome (MDS)" @default.
- Q66046617 P17 Q30 @default.
- Q66046617 P2899 "+18" @default.
- Q66046617 P3098 "NCT03113643" @default.
- Q66046617 P31 Q30612 @default.
- Q66046617 P580 "2017-06-26T00:00:00Z" @default.
- Q66046617 P582 "2020-05-31T00:00:00Z" @default.
- Q66046617 P6099 Q5452194 @default.
- Q66046617 P6153 Q1159198 @default.
- Q66046617 P8363 Q78089383 @default.
- Q66046617 P921 Q954625 @default.